Richard Torbett
@torbettr
MBE - Chief Executive @ABPI_UK Trustee @OHEnews
ID: 1393801172
http://www.abpi.org.uk 01-05-2013 04:47:13
4,4K Tweet
1,1K Takipçi
2,2K Takip Edilen
Our Chief Executive Richard Torbett is at The King's Fund life sciences conference discussing how to future proof the workforce for future advances. He says encouraging clinical research is key. Giving the workforce time to conduct research helps retain staff, benefit patients and bring
Delighted to join such a brilliant panel this afternoon at The King's Fund #KFLifesciences conference. Great discussion on how to support technology adoption in the NHS, engage patients and get the most from partnerships with industry
Happy 1st of December!❄️ All throughout this month we will be celebrating key medical innovations, breakthroughs and developments of the past year – and what is to come. Starting with ABPI Chief Exec Richard Torbett #OurCommonGoal
“We look forward to the network of new centres working closely with industry to offer more patients across the UK the opportunity to participate in studies with cutting-edge treatments.” Richard Torbett ABPI NHS Research Scotland Anna Dominiczak Neil Gray MSP healthandcare.scot/stories/4028/c…
Next up in our Christmas celebration of medical developments...🎄 The rollout of the RSV vaccine is the highlight of the year for NHS England's Medical Director, Prof Sir Stephen Powis. Find out why the RSV vaccine is so important: bit.ly/3DmiHKR #OurCommonGoal
It was great to see Jonathan Reynolds yesterday with other representatives of the UK’s leading manufacturing sectors to discuss the challenges our members face and the vast opportunity the Industrial Strategy has to drive UK growth and investment. ABPI, ADS Group, Chemical Industries Association,
Achieving life sciences sector growth requires falling VPAG payment rates. In this piece, Richard Torbett explains the drivers behind the UK's historic underinvestment in medicine and the unprecedented opportunity to address the issue in 2025. abpi.org.uk/media/blogs/20…
The Department of Health and Social Care is set to demand a third of pharmaceutical company revenue in the second half of 2025 through the Statutory Scheme. abpi.org.uk/media/news/202…
The UK spends less money on medicines than other countries, and we need to think holistically about the benefits that can be achieved from them to help improve people’s health, says Richard Torbett #NHSConfedExpo